Patents
Sitemap › C07 - Organic chemistry › C07H - Sugars; Derivatives thereof; Nucleosides; Nucleotides; Nucleic acids › C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
06/2003
06/18/2003EP1319666A1 Novel antibacterial compounds
06/18/2003EP1319406A1 Novel antibacterial compounds
06/18/2003EP1319013A2 Linker phosphoramidites for oligonucleotide synthesis
06/18/2003EP1158995B1 Biologically active compounds of ganoderma pfeifferi dms 13239
06/18/2003EP1135401B1 Glyceryl nucleotides, method for the production thereof and their use
06/18/2003EP0749423B1 Piperidines and pyrrolidines
06/18/2003CN1424913A Antivirus medicine
06/17/2003US6579976 Process for producing 2′,3′-diethyl substituted nucleoside derivatives
06/17/2003CA2241331C Reusable solid support for oligonucleotide synthesis, process for production thereof and process for use thereof
06/12/2003WO2003048387A2 Labelled nucleotides
06/12/2003WO2003048180A1 Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
06/12/2003WO2003048179A2 Thermolabile hydroxyl protecting groups and methods of use
06/12/2003WO2003048178A2 Nucleotide analogues and their use for nucleic acid sequencing
06/12/2003WO2003048157A1 Processes for preparing ¥â-d-ribofuranose derivatives
06/12/2003WO2003047598A1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists
06/12/2003WO2003047597A1 Combination of crystalline form of a ribofuranosyluronamide derivative and tiotropium salt
06/12/2003WO2003020734A3 Labeled nucleoside polyphosphates
06/12/2003US20030109697 Anticancer agents, infection therapy, autoimmune disease, antiinflammatory agents
06/12/2003US20030109484 Novel 2'-halomethylidene, 2'-ethenylidene and 2'ethynyl cytidine, uridine and guanosine derivatives
06/12/2003US20030108899 Detection hybrids; masking biosynthesis; photosensitive blocking agents; determination accumulated fluorescence radiation
06/12/2003CA2469085A1 Pharmaceutical combinations of adenosine a-2a and beta-2-adrenergic receptor agonists
06/12/2003CA2469066A1 Labelled nucleotides
06/12/2003CA2468432A1 Nucleotide analogues and their use for nucleic acid sequencing
06/11/2003EP1317465A1 Purine derivatives
06/11/2003EP1317464A2 Fluorescent nucleobase conjugates having anionic linkers
06/11/2003CN1423654A Synthesis of 2'-deoxy-L-nucleosides
06/10/2003US6576752 Aminooxy functionalized oligomers
06/10/2003US6576621 Preparation of thioarabinofuranosyl compounds and use thereof
06/10/2003US6576620 Measuring agonist stimulated (35S)GTP gamma S binding to G proteins by compound, measuring extent of agonist stimulated (35S)GTP gamma S binding to G proteins by a full adenosine A1 receptor agonist, selecting compounds with 65-95% binding
06/10/2003US6576619 Orally active A1 adenosine receptor agonists
06/10/2003US6576424 Solid support for use in the determination, classification and mapping of biopolymer sequences
06/05/2003WO2003045968A1 3-β-D-RIBOFURANOSYLTHIAZOLO[4,5-d]PYRIDIMINE NUCLEOSIDES AND USES THEREOF
06/05/2003WO2003045967A1 Aryl fused azapolycyclic compounds
06/05/2003WO2003045966A2 Nucleoside analog libraries
06/05/2003WO2003045907A2 Sir2 products and activities
06/05/2003WO2003045334A2 Methods and compositions for ameliorating the undesirable effects of chemotherapy
06/05/2003US20030105309 Novel bicyclonucleoside and oligonucleotide analogue
06/05/2003US20030105308 Polymerases; gene expression inhibition; gene therapy
06/05/2003US20030105056 Used to produce amino- modified linkers that space an oligonucleotide from a solid support
06/05/2003US20030105053 Therapeutic compositions and screening methods relating to 3' -tyrosyl-DNA-phosphodiesterase
06/05/2003US20030104986 Streptomycin bactericides for treating infections; cultures
06/05/2003US20030104437 Probes for use as tools in determination of nucleotide sequence of target nucleic acids
06/05/2003US20030104411 Microarray for use in analysis and classification of biological samples
06/05/2003US20030104377 Tenascin-C nucleic acid ligands
06/05/2003CA2468717A1 Aryl fused azapolycyclic compounds
06/05/2003CA2467854A1 Sir2 products and activities
06/04/2003EP1316559A1 Adenosine derivatives and use thereof
06/04/2003EP1315736A2 Nucleoside derivatives for the treatment of hepatitis c
06/04/2003EP1315508A1 Purine ribosides as antiarrhythmics
06/04/2003EP1027363B1 Adenosine a1-receptor agonists
06/04/2003EP1025115B1 Novel nucleoside or nucleotide fluorescent conjugates, preparation method and uses
06/04/2003EP0989990B1 Non-sulfonated cyanine dyes for labeling nucleosides and nucleotides
06/04/2003CN1110567C Process for producing deoxynucleoside triphosphate
06/03/2003US6573374 Using carbocyanine group attached to base portion; less background interference
06/03/2003US6573248 Monocyclic L-nucleosides, analogs and uses thereof
06/03/2003US6573247 Prophylaxis or treatment of varicella-zoster virus or cytomegalo virus infections
06/03/2003CA2116224C Novel alpha-mannosidase inhibitors
05/2003
05/30/2003WO2003044035A1 Phospholipid derivatives of nucleosides as antitumoral medicaments
05/30/2003WO2003043633A1 Use of an ascomycin for the treatment of blepharitis
05/30/2003WO2003010141A3 Hepatitis c virus polymerase inhibitors with a heterobicyclic structure
05/30/2003CA2468099A1 Phospholipid derivatives of nucleosides as antitumoral medicaments
05/30/2003CA2467549A1 Use of an ascomycin for the treatment of blepharitis
05/29/2003US20030100759 Selective anti-viral nucleoside chain terminators
05/29/2003US20030099981 Process for the preparation of phosphorothioate triesters
05/29/2003US20030099972 Nucleotide sequences conjugate for use as diagnostic tool in genetic engineering
05/28/2003EP1314734A1 Novel nucleoside analogs and oligonucleotide derivatives containing these analogs
05/28/2003EP1313752A2 Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives
05/28/2003EP1313469A1 Methods of drug delivery to hepatocytes and treatment of flaviviridae infections
05/28/2003EP1231211B1 Thiazolidinedione derivatives as antidiabetic agents
05/28/2003EP1155140B1 Methods for making morpholino-nucleotides, and their use for analysing and marking nucleic acid sequences
05/28/2003EP0817784B1 Process for the synthesis of nucleoside analogues
05/28/2003CN1420779A Nucleoside analogs with carboxamidine-modified bicyclic base
05/28/2003CN1420773A 5-(E)-bromovinyl uracil analogues and related pyrimidine nucleosides as anti-viral agents and methods of use
05/28/2003CN1420723A Compositions and methods for L-nucleosides, and their analogs
05/27/2003US6569858 12,13-(pyranosyl)-indolo[2,3-a]pyrrolo[3,4-c]carbazole and 12,13-(pyranosyl)-furo[3,4-c]indolo[2,3-a]carbazoles
05/27/2003US6569837 β-L-2′-deoxy pyrimidine nucleosides for the treatment of hepatitis B
05/27/2003US6569649 Compositions and methods for saccharide synthesis
05/22/2003WO2003042657A2 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
05/22/2003WO2001068661A9 Crystalline alkycycline derivative
05/22/2003US20030096981 Nucleotide sequences for use in controlling gene expression
05/22/2003US20030096980 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines
05/22/2003US20030096979 Oligonucleotides having A-DNA form and B-DNA form conformational geometry
05/22/2003US20030096830 Pyrrolo(3,2-d)pyrimidin-7-yl)-1,4-imino-D-ribitol derivatives; for suppression of T-cell function
05/22/2003US20030096788 Adenosine derivatives
05/22/2003US20030096765 Aromatic esters; cytotoxic agents; antitumor agents
05/22/2003US20030096253 Single nucleotide amplification and detection by polymerase
05/22/2003US20030095921 Administering a uridine analogue which is activated by thymidylate synthase to reduce or inhibit replication or spread of tumor cells; diagnosing tumors which are resistant to thymidylate synthase inhibitors
05/22/2003CA2465588A1 Detection of nucleic acid sequences by cleavage and separation of tag-containing structures
05/21/2003EP1311526A1 Processes for the preparation of oligonucleotides
05/21/2003EP1311525A2 Composition and method for inhibiting platelet aggregation
05/21/2003EP1311524A2 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients
05/21/2003EP1125945B1 Reversible photocoupling nucleic acid and phosphoroamidite
05/21/2003CN1418966A Resoldution method for racemic compound of nucleoside enantiomorph
05/21/2003CN1109108C Method for resolution of a racemic mixture of nucleoside enantioners
05/21/2003CN1109030C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides
05/20/2003US6566515 Performing photochemical reactions on a surface; prepare chemical mixture, apply to surface, irradiate, monitor generation of reaction product
05/20/2003US6566509 Compound for use as bactericide
05/20/2003US6566495 Biosynthesis of preferential biopolymers; provide substrate, electrically activate preferential positions, bind monomer, repeat, recover biopolymers
05/20/2003US6566344 β-L-2′-deoxy-nucleosides for the treatment of hepatitis B
05/20/2003US6566341 Derivative of isoindigo, indigo and indirubin for the treatment of cancer
1 ... 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 ... 201